← Leaderboards

Roger L Albin

University Of Michigan At Ann Arbor

Google Scholar ↗PubMed ↗ORCID ↗

$10,980,216

Attributed

$12,038,382

Total exposure

27

Grants

21

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.1M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$25,861,523 · 28

VA$0 · 1

By mechanism

P50$17,619,070 · 9

R25$1,311,937 · 1

UG3$1,180,332 · 1

R21$1,109,105 · 3

U24$936,000 · 1

P30$911,217 · 2

Top collaborators

Kelvin L Chou3 shared
Vikas Kotagal1 shared

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Kirk A Frey$5,028,153
Sid Gilman$1,651,756
Michael R Kilbourn$3,886,582
Ari Gafni$9,320,728
Kelvin L Chou$2,335,241

Others in their field

Top investigators on “Functional Disorder”

Randall J Bateman · Washington University$164,791,794
Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
David Heimbrook · Leidos Biomedical Research, Inc.$127,725,513
Ed Lein · Allen Institute$92,850,604
Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
John M Lachin · George Washington University$85,958,868

Research focus

Functional DisorderUniversitiesParkinson DiseaseBaseClinical ResearchMichiganResourcesTrainingPositron-Emission TomographyCommunitiesBrainResearch PersonnelExhibitsCholinergicMentorsProgramsNational Institute Of Neurological Disorders And StrokeMotorCareerAttentionLeadNeurosciencesClinical TrialsPathologic

Grant awards (85)

Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease$2,325,657

P50 · FY2025 · NS · contact PI

Core A: Administrative Core$294,611

P50 · FY2025 · NS · contact PI

UM Clinical Neuroscientist Training Program$125,194

UE5 · FY2025 · NS · contact PI

Project III: Cingulo-Opercular Task Control Network Cholinergic Dysfunction in PD$112,201

P50 · FY2025 · NS · contact PI

Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease$2,260,431

P50 · FY2024 · NS · contact PI

Reducing falls with Varenicline in Hypocholinergic Parkinson disease$1,180,332

UG3 · FY2024 · NS

Core A: Administrative Core$265,748

P50 · FY2024 · NS · contact PI

UM Clinical Neuroscientist Training Program$229,072

UE5 · FY2024 · NS · contact PI

Project III: Cingulo-Opercular Task Control Network Cholinergic Dysfunction in PD$103,463

P50 · FY2024 · NS · contact PI

Research Education Component$96,999

P30 · FY2024 · AG · contact PI

Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease$2,334,226

P50 · FY2023 · NS · contact PI

Core A: Administrative Core$294,611

P50 · FY2023 · NS · contact PI

UM Clinical Neuroscientist Training Program$254,561

R25 · FY2023 · NS · contact PI

Project III: Cingulo-Opercular Task Control Network Cholinergic Dysfunction in PD$105,961

P50 · FY2023 · NS · contact PI

Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease$2,339,061

P50 · FY2022 · NS · contact PI

UM Clinical Neuroscientist Training Program$344,517

R25 · FY2022 · NS · contact PI

Core A: Administrative Core$274,487

P50 · FY2022 · NS · contact PI

Project III: Cingulo-Opercular Task Control Network Cholinergic Dysfunction in PD$112,201

P50 · FY2022 · NS · contact PI

Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease$2,340,000

P50 · FY2021 · NS · contact PI

Core A: Administrative Core$294,611

P50 · FY2021 · NS · contact PI

Project III: Cingulo-Opercular Task Control Network Cholinergic Dysfunction in PD$106,752

P50 · FY2021 · NS · contact PI

UM Clinical Neuroscientist Training Program$102,598

R25 · FY2021 · NS · contact PI

Research Education Component$96,999

P30 · FY2021 · AG · contact PI

Vigor and the LDR in Parkinson disease$390,000

R21 · FY2020 · NS · contact PI

NeuroNEXT Clinical Research Site at the University of Michigan$312,000

U24 · FY2020 · NS

Core F: Research Education Component (RL5)$170,311

P30 · FY2020 · AG · contact PI

UM Clinical Neuroscientist Training Program$96,894

R25 · FY2020 · NS · contact PI

Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease$468,000

P50 · FY2019 · NS · contact PI

NeuroNEXT Clinical Research Site at the University of Michigan$312,000

U24 · FY2019 · NS

Core F: Research Education Component (RL5)$127,726

P30 · FY2019 · AG · contact PI

UM Clinical Neuroscientist Training Program$108,244

R25 · FY2019 · NS · contact PI

Project III, Cholinergic Pathology as an Early Marker of a Parkinson Disease Subgroup$82,017

P50 · FY2019 · NS · contact PI

Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease$1,755,766

P50 · FY2018 · NS · contact PI

NeuroNEXT Clinical Research Site at the University of Michigan$312,000

U24 · FY2018 · NS

alpha4beta2 nAChRs, gait, and balance in PD$149,519

P50 · FY2018 · NS · contact PI

Core F: Research Education Component (RL5)$127,726

P30 · FY2018 · AG · contact PI

UM Clinical Neuroscientist Training Program$41,761

R25 · FY2018 · NS · contact PI

alpha4beta2 nAChRs, gait, and balance in PD$148,464

P50 · FY2017 · NS · contact PI

Core F: Research Education Component (RL5)$138,962

P30 · FY2017 · AG · contact PI

UM Clinical Neuroscientist Training Program$81,869

R25 · FY2017 · NS · contact PI

Core F: Research Education Component (RL5)$152,494

P30 · FY2016 · AG · contact PI

alpha4beta2 nAChRs, gait, and balance in PD$148,803

P50 · FY2016 · NS · contact PI

UM Clinical Neuroscientist Training Program$75,589

R25 · FY2016 · NS · contact PI

Cholinergic Interneurons in Tourette Syndrome$232,563

R21 · FY2015 · NS · contact PI

alpha4beta2 nAChRs, gait, and balance in PD$150,381

P50 · FY2015 · NS · contact PI

UM Clinical Neuroscientist Training Program$124,080

R25 · FY2015 · NS · contact PI

Serotonin and Amyloidopathy$680,124

R56 · FY2014 · NS · contact PI

alpha4beta2 nAChRs, gait, and balance in PD$257,859

P50 · FY2014 · NS · contact PI

Cholinergic Interneurons in Tourette Syndrome$194,375

R21 · FY2014 · NS · contact PI

UM Clinical Neuroscientist Training Program$81,824

R25 · FY2014 · NS · contact PI

NR2B Mediated Neurotoxicity in Murine Huntington Disease Model$0

I01 · FY2013 · VA · contact PI

Serotonin and Sleep Disordered Breathing in Parkinson Disease$91,212

P01 · FY2012 · NS · contact PI

NR2B Mediated Neurotoxicity in Murine Huntington Disease Model$0

I01 · FY2012 · VA · contact PI

Serotonin and Sleep Disordered Breathing in Parkinson Disease$91,212

P01 · FY2011 · NS · contact PI

NR2B Mediated Neurotoxicity in Murine Huntington Disease Model$0

I01 · FY2011 · VA · contact PI

NR2B Mediated Neurotoxicity in Murine Huntington Disease Model$0

I01 · FY2011 · VA · contact PI

Serotonin and Sleep Disordered Breathing in Parkinson Disease$88,191

P01 · FY2010 · NS · contact PI

DIFFERENTIATING DEGENERATIVE DEMENTIA WITH [11C]DTBZ-PET IMAGING$208,779

P50 · FY2009 · AG · contact PI

Neurodegeneration in Aging Retarded Mice$133,263

R21 · FY2009 · NS · contact PI

Serotonin and Sleep Disordered Breathing in Parkinson Disease$89,082

P01 · FY2009 · NS · contact PI

DIFFERENTIATING DEGENERATIVE DEMENTIA WITH [11C]DTBZ-PET IMAGING$205,887

P50 · FY2008 · AG · contact PI

Neurodegeneration in Aging Retarded Mice$158,904

R21 · FY2008 · NS · contact PI

Serotonin and Sleep Disordered Breathing in Parkinson Disease$91,631

P01 · FY2008 · NS · contact PI

DIFFERENTIATING DEGENERATIVE DEMENTIA WITH [11C]DTBZ-PET IMAGING$225,825

P50 · FY2007 · AG · contact PI

Evaluating Striatal Function in a Murine HD Model$66,492

R03 · FY2007 · NS · contact PI

Michigan Parkinson's Disease Clinical Center$43,705

U10 · FY2007 · NS · contact PI

DOPAMINE SYNAPTIC MECHANISMS IN TOURETTE SYNDROME$8,811

M01 · FY2007 · RR · contact PI

DIFFERENTIATING DEGENERATIVE DEMENTIA WITH [11C]DTBZ-PET IMAGING$128,749

P50 · FY2006 · AG · contact PI

Evaluating Striatal Function in a Murine HD Model$67,940

R03 · FY2006 · NS · contact PI

Michigan Parkinson's Disease Clinical Center$30,200

U10 · FY2006 · NS · contact PI

COQ10 AND GPI 1485 IN SUBJECTS WITH EARLY UNTREATED PARKINSON'S$3,066

M01 · FY2006 · RR · contact PI

DIFFERENTIATING DEGENERATIVE DEMENTIA WITH [11C]DTBZ-PET IMAGING$125,000

P50 · FY2005 · AG

Michigan Parkinson's Disease Clinical Center$30,200

U10 · FY2005 · NS

DOPAMINE SYNAPTIC MECHANISMS IN TOURETTE SYNDROME$14,409

M01 · FY2005 · RR

COQ10 AND GPI 1485 IN SUBJECTS WITH EARLY UNTREATED PARKINSON'S$8,749

M01 · FY2005 · RR

MINOCYCLINE &CREATINE IN SUBJECTS W/ EARLY UNTREATED PARKINSON?S DISEASE$5,662

M01 · FY2005 · RR

Minocycline &Creatine in Subjects w/ Early Untreated Parkinson's Disease$6,607

M01 · FY2004 · RR

Michigan Parkinson's Disease Clinical Center$100,876

U10 · FY2003 · NS

MURINE MODEL OF CAG REPEAT DISEASES$260,496

R01 · FY2002 · NS

Michigan Parkinson's Disease Clinical Center$100,957

U10 · FY2002 · NS

DOPAMINE SYNAPTIC MECHANISMS IN TOURETTE'S SYNDROME$0

P01 · FY2002 · NS

MURINE MODEL OF CAG REPEAT DISEASES$253,621

R01 · FY2001 · NS

DOPAMINE SYNAPTIC MECHANISMS IN TOURETTE'S SYNDROME$0

P01 · FY2001 · NS

MURINE MODEL OF CAG REPEAT DISEASES$256,353

R01 · FY2000 · NS

MURINE MODEL OF CAG REPEAT DISEASES$50,000

R01 · FY2000 · NS